Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilda Garay

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|June 9, 2017
Development and validation of a bioanalytical method based on LC-MS/MS analysis for the quantitation of CIGB-814 peptide in plasma from Rheumatoid Arthritis patientsAnia Cabrales-Rico, Yassel Ramos, Vladimir Besada, et al.
Human & Experimental Toxicology|February 3, 2022
Preliminary safety assessment of CIGB-210, an investigational peptide for HIV infectionAnna C Ramírez-Suárez, Taimi Paneque-Guerrero, Dionne Casillas-Casanova, et al.
Advances in Experimental Medicine and Biology|May 24, 2008
Gonadotrophin releasing hormone-based vaccine, an effective candidate for prostate cancer and other hormone-sensitive neoplasmsJesús A Junco, Roberto Basalto, Franklin Fuentes, et al.
Vaccine|August 28, 2012
Very small size proteoliposomes (VSSP) and Montanide combination enhance the humoral immuno response in a GnRH based vaccine directed to prostate cancerFranklin Fuentes Aguilar, Jesús Junco Barranco, Eddy Bover Fuentes, et al.
Journal of Experimental Therapeutics & Oncology|November 22, 2017
The influence of different peptide combinations to increase the immunogenicity of the Gonadotrophin Releasing Hormone Vaccine for prostate cancer treatmentFranklin Fuentes Aguilar, Jesús Junco Barranco, Lesvia Calzada Aguilera, et al.
Viruses|June 18, 2016
Identification of Vimentin as a Potential Therapeutic Target against HIV InfectionCelia Fernández-Ortega, Anna Ramírez, Dionne Casillas, et al.
Vaccine|November 21, 2007
Immunotherapy of prostate cancer in a murine model using a novel GnRH based vaccine candidateJesús A Junco, Peter Peschke, Ivan Zuna, et al.
International Journal of Nanomedicine|August 27, 2016
The intrinsic antimicrobial activity of citric acid-coated manganese ferrite nanoparticles is enhanced after conjugation with the antifungal peptide Cm-p5Carlos Lopez-Abarrategui, Viviana Figueroa-Espi, Maria B Lugo-Alvarez, et al.
Biochemistry and Biophysics Reports|September 29, 2017
Comparative proteomic analysis of growth hormone secretagogue A233 treatment of murine macrophage cells J774A.2 indicates it has a role in antiviral innate responseRebeca Martínez, Teresa Núñez de Villavicencio-Díaz, Aniel Sánchez, et al.
Oncology Letters|July 23, 2016
Gradual reduction of testosterone using a gonadotropin-releasing hormone vaccination delays castration resistance in a prostate cancer modelJesús A Junco Barranco, Robert P Millar, Franklin Fuentes, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Pharmaceutical and Biomedical Analysis|June 9, 2017
Development and validation of a bioanalytical method based on LC-MS/MS analysis for the quantitation of CIGB-814 peptide in plasma from Rheumatoid Arthritis patientsAnia Cabrales-Rico, Yassel Ramos, Vladimir Besada, et al.
Human & Experimental Toxicology|February 3, 2022
Preliminary safety assessment of CIGB-210, an investigational peptide for HIV infectionAnna C Ramírez-Suárez, Taimi Paneque-Guerrero, Dionne Casillas-Casanova, et al.
Advances in Experimental Medicine and Biology|May 24, 2008
Gonadotrophin releasing hormone-based vaccine, an effective candidate for prostate cancer and other hormone-sensitive neoplasmsJesús A Junco, Roberto Basalto, Franklin Fuentes, et al.
Vaccine|August 28, 2012
Very small size proteoliposomes (VSSP) and Montanide combination enhance the humoral immuno response in a GnRH based vaccine directed to prostate cancerFranklin Fuentes Aguilar, Jesús Junco Barranco, Eddy Bover Fuentes, et al.
Journal of Experimental Therapeutics & Oncology|November 22, 2017
The influence of different peptide combinations to increase the immunogenicity of the Gonadotrophin Releasing Hormone Vaccine for prostate cancer treatmentFranklin Fuentes Aguilar, Jesús Junco Barranco, Lesvia Calzada Aguilera, et al.
Viruses|June 18, 2016
Identification of Vimentin as a Potential Therapeutic Target against HIV InfectionCelia Fernández-Ortega, Anna Ramírez, Dionne Casillas, et al.
Vaccine|November 21, 2007
Immunotherapy of prostate cancer in a murine model using a novel GnRH based vaccine candidateJesús A Junco, Peter Peschke, Ivan Zuna, et al.
International Journal of Nanomedicine|August 27, 2016
The intrinsic antimicrobial activity of citric acid-coated manganese ferrite nanoparticles is enhanced after conjugation with the antifungal peptide Cm-p5Carlos Lopez-Abarrategui, Viviana Figueroa-Espi, Maria B Lugo-Alvarez, et al.
Biochemistry and Biophysics Reports|September 29, 2017
Comparative proteomic analysis of growth hormone secretagogue A233 treatment of murine macrophage cells J774A.2 indicates it has a role in antiviral innate responseRebeca Martínez, Teresa Núñez de Villavicencio-Díaz, Aniel Sánchez, et al.
Oncology Letters|July 23, 2016
Gradual reduction of testosterone using a gonadotropin-releasing hormone vaccination delays castration resistance in a prostate cancer modelJesús A Junco Barranco, Robert P Millar, Franklin Fuentes, et al.
Pageof 4